Pharmacology & ToxicologyJournal of Medicinal ChemistryPeer-reviewed
Discovery of AVI-6451, a Potent and Selective Inhibitor of the SARS-CoV-2 ADP-Ribosylhydrolase Mac1 with Oral Efficacy in vivo
Priyadarshini Jaishankar, G.J. Correy, Yusuke Matsui…·Adam R. Renslo
This paper identifies AVI-6451, an orally bioavailable inhibitor of SARS-CoV-2 Mac1 with once-daily efficacy in a mouse model.
6 citationstop 4%